Molecular diagnostics of thyroid tumors

Yuri E Nikiforov1

  • 1Department of Pathology and Laboratory Medicine, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA. nikiforovye@upmc.edu

Summary

Common molecular alterations like BRAF and RAS mutations are key for diagnosing and predicting outcomes in thyroid cancer. These genetic markers improve accuracy in thyroid nodule diagnosis and personalized patient management.